Finian McGrath (Dublin Bay North, Independent) | Oireachtas source

The Deputy is right that the decision is expected very soon. According to the memo I received from the HSE, it will be in the first quarter of 2018, and while I hear that it could be in the next couple of days, that will be announced independently. It is very important that the HSE is the decision-making body on the reimbursement of medicines under the Health (Pricing and Supply of Medical Goods) Act 2013. It is the HSE, and the HSE alone, which will make the final decision on whether Kuvan will be reimbursed, taking into consideration the statutory criteria as specified under the 2013 Act. This Act does not give the Minister for Health any powers in the reimbursement process. The HSE does not require approval or consent from the Minister or the Government when it is making a reimbursement decision.

See this speech in context